Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
HSIC
#976
Henry Schein Inc
77.2
0
USD
+1.59%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.59%
Changement Mensuel
+1.93%
Evolution sur 6 mois
+21.79%
Changement Annuel
+19.69%
Clôture Précédente
75.9
9
Open
77.2
0
Bid
Ask
Low
77.2
0
High
77.2
0
Volume
214
Marchés
Actions des Marchés US
Soins de Santé
HSIC
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
7.77 B
8.48 B
8.61 B
10.57 B
10.22 B
11.21 B
Total liabilities
3.46 B
3.8 B
3.94 B
5.42 B
5.38 B
6.42 B
Total equity
3.98 B
4.06 B
4.09 B
4.29 B
4.03 B
3.9 B
Total liabilities & shareholders' equities
7.77 B
8.48 B
8.61 B
10.57 B
10.22 B
11.21 B
Total debt
302.64 M
343.17 M
1.39 B
389 M
—
—
Net debt
302.64 M
225.2 M
1.28 B
218 M
—
—
Henry Schein Inc
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.
Nouvelles
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
What to Expect From Henry Schein’s Q1 2026 Earnings Report
Le conseil d’administration d’Henry Schein réduit à 10 membres
Should You Retain Henry Schein Stock in Your Portfolio for Now?
ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?
Align Technology: Only International Growth Can Save Them Now (Downgrade) (NASDAQ:ALGN)
Les meilleures actions de technologie médicale selon Piper Sandler
Henry Schein à la conférence Barclays : expansion numérique et gains de parts de marché
Henry Schein at Barclays Conference: Digital Expansion and Market Gains
Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Leerink Partners réitère sa note sur l’action Henry Schein avec un objectif de 87$
Leerink Partners reiterates Henry Schein stock rating at $87 target